MyFinsight
Home
Blog
About
Contact
Download
Download image
Foreign currency
translation adjustment
$3,531K
Unrealized gain on
available-for-sale securities
-$126K
Comprehensive loss
-$309,106K
Total other
comprehensive income (loss)
$3,657K
Net loss
-$312,763K
Income tax benefit
-$837K
Interest income
$22,616K
Research and development
$158,541K
Cost of
revenue-Service
$28,897K
General and
administrative
$27,443K
General and
administrative
$56,532K
Cost of revenue
$13,203K
Loss before income
taxes
-$313,600K
Total other income
(expense)
$1,678K
Cell Engineering
Segment
$132,746K
Biosecurity
Segment-Service
$37,409K
Loss on investments
-$16,411K
Other (expense)
income, net
-$4,527K
Loss from operations
-$95,530K
Loss from operations
-$18,931K
Loss from operations
-$315,278K
Total revenue
$170,155K
Total operating
expenses
$485,433K
Research and development
$243,773K
General and
administrative
$183,290K
Cost of
revenue-Service
$31,521K
Cost of
revenue-Product And Service...
$15,451K
Restructuring charges
$11,398K
Back
Back
Income Statement
source: myfinsight.com
Ginkgo Bioworks Holdings, Inc. (DNABW)
Ginkgo Bioworks Holdings, Inc. (DNABW)